- Published at
- by globenewswire.com
positive
positive
Oxurion Share Consolidation
Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the Company), a biopharmaceutical company...
News for Oxurion NV (OXUR.BR)
- Published at
- by globenewswire.com
positivepositiveInformation on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 4...- Published at
- by globenewswire.com
positivepositiveOxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 – 06:00 PM CET - Oxurion NV (Euronext...- Published at
- by globenewswire.com
positivepositiveOxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024
Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Leuven, BELGIUM – July 11, 2024...- Published at
- by globenewswire.com
positivepositiveOxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production LEUVEN,...- Published at
- by globenewswire.com
positivepositiveOxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024
Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024. Leuven, BELGIUM - 4...- Published at
- by globenewswire.com
positivepositiveOxurion Announces Extraordinary General Shareholders’ Meeting
Oxurion Announces Extraordinary General Shareholders’ Meeting Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a...- Published at
- by investing.com
positivepositiveOxurion Receives Transparency Notification from Atlas Special Opportunities LLC By Investing.com
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC- Published at
- by marketscreener.com
positivepositiveOxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 Leuven, BELGIUM – 23 May, 2024 – 07.00 PM CET – Oxurion NV , a biopharmaceutical company headquartered in Leuven,...- Published at
- by investing.com
positivepositiveInformation on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas By Investing.com
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas- Published at
- by benzinga.com
mixedmixedOphthalmic drugs Market Size Estimated to Surpass USD 37,700 Million By 2026, Globally: Facts & Factors
New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled "Ophthalmic Drug Market By Type ...- Published at
- by benzinga.com
negativenegativeRetinal Biologics Market to hit US $18.3 billion by 2028 - Global Insights on Trends, Growth Drivers, Investment Plans, Expansion Analysis, COVID-18 Impact, Key Players and Future Opportunities: Adroi
Dallas, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The global retinal biologics market is projected to grow at a CAGR of 6.5%. Increasing prevalence of ...